Yansong Lin

1.8k total citations
104 papers, 1.1k citations indexed

About

Yansong Lin is a scholar working on Endocrinology, Diabetes and Metabolism, Radiology, Nuclear Medicine and Imaging and Surgery. According to data from OpenAlex, Yansong Lin has authored 104 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 84 papers in Endocrinology, Diabetes and Metabolism, 27 papers in Radiology, Nuclear Medicine and Imaging and 23 papers in Surgery. Recurrent topics in Yansong Lin's work include Thyroid Cancer Diagnosis and Treatment (83 papers), Thyroid Disorders and Treatments (17 papers) and Thyroid and Parathyroid Surgery (14 papers). Yansong Lin is often cited by papers focused on Thyroid Cancer Diagnosis and Treatment (83 papers), Thyroid Disorders and Treatments (17 papers) and Thyroid and Parathyroid Surgery (14 papers). Yansong Lin collaborates with scholars based in China, Japan and United States. Yansong Lin's co-authors include Jun Liang, Xiaoyi Li, Xin Zhang, Zhiyong Liang, Chen Wang, Teng Zhao, Yanqing Liu, Xue Yang, Ke Yang and Wen Gao and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and The Journal of Clinical Endocrinology & Metabolism.

In The Last Decade

Yansong Lin

96 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yansong Lin China 19 903 286 265 209 204 104 1.1k
Kenichi Matsuzu Japan 18 815 0.9× 85 0.3× 428 1.6× 159 0.8× 173 0.8× 57 1.0k
Matti L. Gild Australia 16 511 0.6× 89 0.3× 142 0.5× 208 1.0× 254 1.2× 53 824
Ning Qu China 22 623 0.7× 108 0.4× 310 1.2× 358 1.7× 283 1.4× 64 1.2k
Ronald A. Ghossein United States 6 686 0.8× 76 0.3× 194 0.7× 267 1.3× 288 1.4× 8 1.0k
Virginia Cappagli Italy 18 868 1.0× 79 0.3× 233 0.9× 238 1.1× 308 1.5× 38 1.1k
Jiachao Liang United States 7 554 0.6× 111 0.4× 79 0.3× 134 0.6× 294 1.4× 12 790
Junko Akaishi Japan 22 1.1k 1.2× 82 0.3× 520 2.0× 290 1.4× 291 1.4× 58 1.5k
Jingqiang Zhu China 17 507 0.6× 93 0.3× 316 1.2× 158 0.8× 143 0.7× 47 740
Rébecca Leboeuf United States 16 1.8k 2.0× 362 1.3× 760 2.9× 314 1.5× 335 1.6× 21 2.1k
Jan Włoch Poland 15 787 0.9× 64 0.2× 379 1.4× 291 1.4× 170 0.8× 51 1.1k

Countries citing papers authored by Yansong Lin

Since Specialization
Citations

This map shows the geographic impact of Yansong Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yansong Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yansong Lin more than expected).

Fields of papers citing papers by Yansong Lin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yansong Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yansong Lin. The network helps show where Yansong Lin may publish in the future.

Co-authorship network of co-authors of Yansong Lin

This figure shows the co-authorship network connecting the top 25 collaborators of Yansong Lin. A scholar is included among the top collaborators of Yansong Lin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yansong Lin. Yansong Lin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Fu, Lingyi, Jie Mei, Ziteng Li, et al.. (2025). BIRC2 blockade facilitates immunotherapy of hepatocellular carcinoma. Molecular Cancer. 24(1). 113–113. 3 indexed citations
2.
Li, Hui, Yì Wáng, Lê Hữu Song, et al.. (2024). Evaluation of fibroinflammatory activity in thyroid eye disease using [18F]AlF-NOTA-FAPI-04 PET/CT: A prospective study. European Journal of Nuclear Medicine and Molecular Imaging. 52(5). 1890–1900. 1 indexed citations
3.
Meng, Chao, et al.. (2023). A user-friendly nomogram for predicting radioiodine refractory differentiated thyroid cancer. Frontiers in Endocrinology. 14. 1109439–1109439. 10 indexed citations
4.
Zhang, Bin, Xiaozhi Zhao, Tianyu Chen, Sumei Ren, & Yansong Lin. (2023). The accuracy of infrared thermal imaging and ultrasound in evaluating knee osteoarthritis dysfunction. 21(3). 447–451. 2 indexed citations
5.
Sun, Di, Gaoda Ju, Lisha Huang, et al.. (2023). Characterizing Genetic Alterations Related to Radioiodine Avidity in Metastatic Thyroid Cancer. The Journal of Clinical Endocrinology & Metabolism. 109(5). 1231–1240. 9 indexed citations
6.
Ju, Gaoda, Hao Wang, Xin Zhang, et al.. (2023). Fusion Oncogenes in Patients With Locally Advanced or Distant Metastatic Differentiated Thyroid Cancer. The Journal of Clinical Endocrinology & Metabolism. 109(2). 505–515. 7 indexed citations
7.
Shi, Liang, Jun Wang, Hanjin Wang, et al.. (2022). Antitumour effects of apatinib in progressive, metastatic differentiated thyroid cancer (DTC). Endocrine. 78(1). 68–76. 2 indexed citations
8.
Sun, Di, et al.. (2022). Radioiodine adjuvant therapy in differentiated thyroid cancer: An update and reconsideration. Frontiers in Endocrinology. 13. 994288–994288. 12 indexed citations
9.
Zheng, Xiangqian, Zhengang Xu, Qinghai Ji, et al.. (2021). A Randomized, Phase III Study of Lenvatinib in Chinese Patients with Radioiodine-Refractory Differentiated Thyroid Cancer. Clinical Cancer Research. 27(20). 5502–5509. 31 indexed citations
12.
Liang, Jun, et al.. (2019). Relationship between preablative stimulated thyroglobulin and the excellent response in differentiated thyroid carcinoma. Zhongguo aizheng zazhi. 29(2). 125–130. 2 indexed citations
13.
Wang, Chen, Teng Zhao, Li Jiao, Wen Gao, & Yansong Lin. (2017). Relationship between the initial change of Tg and outcome in differentiated thyroid carcinoma patients with pulmonary metastases after 131I treatment. 37(9). 555–558. 1 indexed citations
14.
Zhang, Na, Jun Liang, & Yansong Lin. (2017). Unfavorable efficacy to 131I ablation in BRAFV600E mutant papillary thyroid carcinoma with positive TgAb. Oncotarget. 8(57). 97407–97415. 3 indexed citations
15.
Wang, Chen, Teng Zhao, Hui Li, Wen Gao, & Yansong Lin. (2017). Low activity versus high activity. Nuclear Medicine Communications. 38(5). 366–371. 7 indexed citations
17.
Lin, Yansong. (2015). Internal radiation therapy: a neglected aspect of nuclear medicine in the molecular era. Journal of Biomedical Research. 29(5). 345–345. 13 indexed citations
18.
Zhao, Dan, Jun Liang, & Yansong Lin. (2013). Progress in diagnosis and treatment of radioactive iodine-refractory differentiated thyroid carcinomas. 33(6). 505–509. 1 indexed citations
19.
Lin, Yansong, Jun Liang, Xiaoyi Li, et al.. (2012). The value of pre-ablation stimulated thyroglobulin in predicting distant metastasis of papillary thyroid cancer. 32(3). 189–191. 9 indexed citations
20.
Chen, Yonghui, Yanru Ma, Yansong Lin, et al.. (2012). Comparison of different 131 I doses for thyroid remnant ablation in patients with differentiated thyroid carcinoma. 32(1). 39–41. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026